EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
13/03/2025 - 3:00 pm to 4:00 pm
14/03/2025 - 9:00 am to 10:00 am
Room 18+19 (13/03/2025) & Auditorium 10 (14/03/2025)
Clément Delage
Link to EAHP Statements
Section 4 – Clinical Pharmacy: Statements – 4.1, 4.2, 4.3, 4.4, 4.6, 4.8
Section 5 – Patient Safety and Quality Assurance: Statements
Abstract
The advent of artificial intelligence (AI) has open new horizons and raised crucial questions in the healthcare environment, and clinical pharmacy is no exception. AI, for instance, has now the capability to autonomously detect potentially inappropriate prescriptions by considering patient records, biological analyses, medical history, and physiopathological conditions, and it can do this almost instantaneously for an entire hospital. Consequently, numerous questions arise. What is the relevance and quality of AI’s pharmaceutical analyses? Can and should we rely on it? What level of control will we have over its analyses? Does AI threaten the existence of the clinical pharmacist? Behind these questions lies a central concern, the focal point of this seminar: does AI jeopardise the role of the clinical pharmacist, or is it an ally that will become indispensable in optimizing patient safety?
Throughout the presentations, we will first delve into the intricate ecosystem of AI to understand its inner workings. Predictive modelling, big data analysis, and machine learning are techniques that must be understood to assess the advantages and limitations of AI in clinical pharmacy. Subsequently, we will examine its practical integration in clinical pharmacy practice through tools aiding pharmaceutical analysis or via the utilisation of technologies such as ChatGPT as a new source of information.
This session aims to provoke thoughtful reflections on the future of AI in clinical pharmacy, emphasizing its potential and emerging opportunities while also addressing its inherent challenges and limitations. Because beyond the complex mechanisms of AI, our mission remains unchanged: to ensure the safety and well-being of our patients. So, if you’re wondering ‘Will AI replace the clinical pharmacist?’, join us for this seminar. While we may not be able to provide a definitive answer to that question, we hope to drive you to the real one: “Will the clinical pharmacist who uses AI replace the clinical pharmacist who doesn’t?”.
Learning objectives
After the session, the participant should be able to:
Educational need addressed
This conference will provide an overview of the AI tools available in the field of clinical pharmacy. It will present the opportunities they offer for the clinical pharmacist in optimising patient safety and the limitations they present in terms of effectiveness and use.
Keywords
Adverse Drug Reactions, Clinical Decision Support, Documentation, Drug Interactions, Medication Safety, Medication Therapy Management.
